Results 1 to 10 of about 50,642 (116)

A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems

open access: yesFrontiers in Nutrition, 2021
Recently, owing to well-controlled release, enhanced distribution and increased permeability, nanocarriers used for alternative drug and food-delivery strategies have received increasingly attentions.
Qihe Chen, Hongyun Lu
exaly   +3 more sources

Beta-cyclodextrin-based polymerized nanocarriers for doxorubicin delivery to cancer cells [PDF]

open access: yesNanoscale Advances
In-depth drug penetration is significant for achieving optimal therapeutic effects; particularly, anticancer drugs must penetrate deep into tumours to exert toxic effects on cancer cells. Drug-loaded nanocarriers are promising for targeted drug delivery.
Maryam Aslam   +7 more
doaj   +2 more sources

Deformable nanocarriers for enhanced drug delivery and cancer therapy

open access: yesExploration
Recently, the field of nanomedicine has witnessed substantial advancements in the development of nanocarriers for targeted drug delivery, emerges as promising platforms to enhance therapeutic efficacy and minimize adverse effects associated with ...
Xian-Zhu Yang, Cao Ziyang
exaly   +2 more sources

Overcoming chemotherapy resistance in diffuse large B-cell lymphoma using multifunctional nanocarriers: current advances and clinical challenges [PDF]

open access: yesDiscover Nano
Chemoresistance is a primary challenge in diffuse large B-cell lymphoma (DLBCL) treatment. The review is developed to explore the potential of the nanocarrier strategy to minimize resistance in DLBCL treatment.
Danyang Li, Xiaoyan Ke, Kai Hu
doaj   +2 more sources

Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

open access: yesPharmaceutical Fronts, 2022
Lipid-based nanocarriers have been extensively investigated for drug delivery due to their advantages including biodegradability, biocompatibility, nontoxicity, and nonimmunogenicity. However, the shortcomings of traditional lipid-based nanocarriers such
Yan-Qi Zhao   +6 more
doaj   +1 more source

The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers

open access: yesActa Pharmaceutica Sinica B, 2022
The long-circulating effect is revisited by simultaneous monitoring of the drug payloads and nanocarriers following intravenous administration of doxorubicin (DOX)-loaded methoxy polyethylene glycol-polycaprolactone (mPEG-PCL) nanoparticles.
Wufa Fan   +8 more
doaj   +1 more source

Stimuli-responsive nanocarriers for therapeutic applications in cancer

open access: yesCancer Biology & Medicine, 2021
Cancer has become a very serious challenge with aging of the human population. Advances in nanotechnology have provided new perspectives in the treatment of cancer.
Xubo Zhao, Jie Bai, Wenjing Yang
doaj   +1 more source

Targeted Drug Delivery for Sustainable Crop Protection: Transport and Stability of Polymeric Nanocarriers in Plants

open access: yesAdvanced Science, 2021
Spraying of agrochemicals (pesticides, fertilizers) causes environmental pollution on a million‐ton scale. A sustainable alternative is target‐specific, on‐demand drug delivery by polymeric nanocarriers.
Sebastian J. Beckers   +5 more
doaj   +1 more source

Add Sugar to Chitosan: Mucoadhesion and In Vitro Intestinal Permeability of Mannosylated Chitosan Nanocarriers

open access: yesPharmaceutics, 2022
Crosslinked chitosan nanocarriers (140–160 nm) entrapping coumarin-6 (λex/em = 455/508 nm) with or without surface mannosylation were synthesized and assessed for cytotoxicity, adherence and cellular uptake in Caco-2 cells, flux across Caco-2 monolayers,
Sadaf Ejaz   +5 more
doaj   +1 more source

Nanocarriers Call the Last Shot in the Treatment of Brain Cancers

open access: yesTechnology in Cancer Research & Treatment, 2022
Our brain is protected by physio-biological barriers. The blood–brain barrier (BBB) main mechanism of protection relates to the abundance of tight junctions (TJs) and efflux pumps.
Amin Mehrabian PharmD, PhD   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy